Get the Stockscreener App
0.7864
0.57%
-0.0045
Pre-market:
.83
0.0436
+5.54%
Hyperfine Inc stock is traded at $0.7864, with a volume of 249.37K.
It is down -0.57% in the last 24 hours and down -17.22% over the past month.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
See More
Previous Close:
$0.7909
Open:
$0.791
24h Volume:
249.37K
Relative Volume:
0.26
Market Cap:
$83.40M
Revenue:
$15.33M
Net Income/Loss:
$-34.78M
P/E Ratio:
-1.9241
EPS:
-0.4087
Net Cash Flow:
$-28.66M
1W Performance:
-6.05%
1M Performance:
-17.22%
6M Performance:
-32.21%
1Y Performance:
-40.42%
1-Day Range:
$0.7802
$0.8235
1-Week Range:
$0.7802
$0.8388
52-Week Range:
$0.7802
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
Name
Hyperfine Inc
Sector
Industry
Phone
866-796-6767
Address
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.7864 | 83.40M | 15.33M | -34.78M | -28.66M | -0.4087 |
ABT
Abbott Laboratories
|
103.36 | 178.85B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.19B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 103.57B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 62.46B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 50.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-31-22 | Initiated | Evercore ISI | Outperform |
| Apr-14-22 | Initiated | Wells Fargo | Overweight |
Hyperfine Inc Stock (HYPR) Latest News
Lioness Medtech Showcasing Hyperfine Swoop at Röntgenveckan 2026 - marketscreener.com
HYPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hyperfine (HYPR) Holds at $0.81, Pressing Against Support After Mild PullbackMarket Neutral Pair - siam.in
Hyperfine Forms Global Neurosurgery Advisory Council - Medical Product Outsourcing
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Yahoo Finance
Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Nigeria
Hyperfine reports 3,000 scans completed in first office year - Investing.com
Hyperfine (HYPR) Earnings Update: The Available Earnings Metric Delivers a Beat at the Close; Market Response: Shares Finish 4.21% Down for the Current SessionEnergy Earnings Report - vinanet.vn
HYPR | Hyperfine, Inc. Class A FinancialsRevenue Breakdown - Quiver Quantitative
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com
BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada
BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com
Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing
Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire
Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerEarnings Momentum Score - vinanet.vn
HYPR Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Stability Report - vinanet.vn
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeLiquidity Order Flow - vinanet.vn
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
HYPR Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 2.83%EPS Growth Report - vinanet.vn
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates - Investing.com
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Hyperfine : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
Hyperfine (HYPR) Releases Q2 2026 Earnings: Revenue Growth but EPS in Line - Quiver Quantitative
Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows - TradingKey
Hyperfine, Inc. Q2 2026: Revenue $3.904M, EPS $(0.09) — 10-Q Summary - TradingView
Portable MRI maker Hyperfine's Q2 revenue rises less than expected - TradingView
Hyperfine, Inc. (HYPR) Q2 FY2026 earnings call transcript - Yahoo Finance
Hyperfine reports Q2 2026 revenue $3.9M, net loss $9.3M, expands international approvals - TradingView
Hyperfine, Inc. (NASDAQ: HYPR) grows Q2 sales but remains unprofitable - Stock Titan
Hyperfine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Hyperfine (Nasdaq: HYPR) grows Q2 2026 revenue 44.8% as cash rises to $43.5M - Stock Titan
HYPR: Q2 2026 delivered robust revenue growth, margin expansion, and accelerated global adoption - TradingView
BRIEF-Hyperfine, Inc. Q2 EPS USD -0.09 - TradingView
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results - Business Wire
Earnings To Watch: Hyperfine Inc (HYPR) Q2 2026 -- GF Value Sees 72% Upside - Yahoo Finance
Hyperfine Inc. (HYPR) Climbs to $1.03 as Bullish Traders Test ResistanceGolden Cross - dars.gov.et
Hyperfine Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Hyperfine, Inc. Revenue Breakdown – NASDAQ:HYPR - TradingView
Hyperfine Inc. (HYPR) Gains 4.15% as Stock Tests Key Resistance at $0.98MFI Oversold - dars.gov.et
Hyperfine’s portable MRI system featured in medical journals - Investing.com
Hyperfine Inc Stock (HYPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):